KalVista Pharmaceuticals, Inc. (KALV) Social Stream



KalVista Pharmaceuticals, Inc. (KALV): $16.80

-0.65 (-3.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

KalVista Pharmaceuticals Inc (KALV) Price Targets From Analysts

Use the tables below to see what analysts covering KalVista Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
7 $61 $48 $55.71 $17.17 224.46%

The Trend in the Analyst Price Target


KALV's average price target has moved up $25.85 over the prior 55 days.

KALV reports an average of 70.99% for its upside potential over the past 40 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-03-09 7 61 48 55.71 31.47 77.03%
2021-03-05 7 61 48 55.71 30.88 80.41%
2021-01-13 7 39 21 29.86 16.41 81.96%
2021-01-09 7 39 21 29.86 16.64 79.45%
2021-01-02 7 39 21 29.86 18.99 57.24%
2020-11-23 7 39 21 29.71 18.25 62.79%
2020-11-13 7 39 21 29.71 18.80 58.03%
2020-09-23 7 33 21 28.14 NA NA%
2020-09-14 8 33 19 27.00 NA NA%
2020-07-01 8 33 19 27.00 NA NA%
2020-06-12 8 31 19 27.12 NA NA%
2020-06-02 7 31 19 26.71 NA NA%

KALV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.29 3 4 0 0 0 7

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • KALV has a greater upside potential (average analyst target price relative to current price) than 90.56% of all US stocks.
  • KalVista Pharmaceuticals Inc's average analyst price target is greater than 89.71% of stocks in the small market cap category.
  • KalVista Pharmaceuticals Inc's number of analysts covering the stock is higher than 87.98% of stocks in the small market cap category.
  • The variance in analysts' estimates of KALV is less than 71.57% of Pharmaceutical Products stocks.

Stocks similar to KalVista Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FMTX, MIRM and PRQR.

Is KALV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6829 seconds.